RIPK3 promotes islet amyloid-induced β-cell loss and glucose intolerance in a humanized mouse model of type 2 diabetes is a research paper published in Molecular Metabolism (2024). On theSindex it has a DataRank of 0.406. It has been cited 14 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.406
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NIDDK NIH HHS
Grant: P30 DK017047
NIDDK NIH HHS
Grant: P30 DK097512
NIDDK NIH HHS
Grant: T32 DK007247
BLRD VA
Grant: I01 BX001060
BLRD VA
Grant: IK2 BX004659
National Institutes of Health
Grant: 2P30DK017047-42
Diabetes Research Center
National Institutes of Health
Grant: 5P30DK097512-08
Indiana Diabetes Research Center
National Institutes of Health
Grant: 3T32DK064466-14S1
Research Training Program in Diabetes and Obesity
Ralph W and Grace M Showalter Research Trust Fund
US Department of Veterans Affairs
National Institute of Diabetes and Digestive and Kidney Diseases
FWCI
3.45
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals